Synfacts 2005(0): 0013-0013  
DOI: 10.1055/s-2005-865339
Synthesis of Natural Products and Drugs
© Georg Thieme Verlag Stuttgart · New York

Total Synthesis of Caprazol

Contributor(s): Philip Kocienski
S. Hirano, S. Ichikawa, A. Matsuda*
Hokkaido University, Japan
Total Synthesis of Caprazol, a Core Structure of the Caprazamycin Antituberculosis Antibiotics
Angew. Chem. Int. Ed.  2005,  44:  1854-1856  
Further Information

Publication History

Publication Date:
20 July 2005 (online)


Significance

Caprazol is the core structure of the Caprazamycin antibiotics. The Caprazamycins are isolated from Streptomyces sp MK730-62F2. They inhibit Mra Y, a key enzyme in peptidoglycan synthesis in Mycobacterium tuberculosis. They have no significant toxicity to mice.

Comment

Key steps in the 18-step synthesis of Caprazol were (a) a Sharpless asymmetric aminohydroxylation reaction which converts A to B; glycosylation using a 5-aminoribosyl fluoride C; and (c) a reductive amination to create the diazepa­none ring. The stereochemistry of the difficult glycosylation depended strongly on the steric bulk of the 3-pentylidene protecting group and the Lewis acid activator. With BF3·OEt2 at -30 °C, the anomeric ratio was α:β = 4:96.